Genomics IP Trial Between Illumina And Ariosa Kicks Off
A California federal jury trial over two DNA testing patents kicked off Monday with genomics company Illumina arguing that Ariosa Diagnostics' prenatal testing technology infringed its patents, while Ariosa countered that...To view the full article, register now.
Already a subscriber? Click here to view full article